Cadherin switching in ovarian cancer progression

International Journal of Cancer

Volumn 106, Issue 2, 2003, Pages 172-177

  Patel, Ila S ^a   Madan, Pavneesh ^a   Getsios, Spiro ^a   Bertrand, Monique A ^a   MacCalman, Colin D ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Cadherins; Ovarian cancer; Ovarian surface epithelium; P cadherin; Peritoneum; Tumor progression

Indexed keywords

BETA CATENIN; CADHERIN; CADHERIN 11; CADHERIN 4; CADHERIN 6; CELL ADHESION MOLECULE; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; P CADHERIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CONTROLLED STUDY; EARLY CANCER; EFFUSION; EPITHELIUM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SWITCHING; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALIGNANT EFFUSION; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVARY SURFACE EPITHELIUM; PERITONEUM; PERITONEUM EFFUSION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH; WESTERN BLOTTING;

ASCITIC FLUID; BETA CATENIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CADHERINS; CYTOSKELETAL PROTEINS; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEUM; PLEURAL EFFUSION, MALIGNANT; POLYMERASE CHAIN REACTION; PRECIPITIN TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 0037479904     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11086     Document Type: Article

References (45)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1999. CA Cancer J 1999;49:8-31.
2. Cannistra SA, Kansas GS, Niloff J, DeFranzo B, Kim Y, Ottensmeier C. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res 1993;53:3830-8.
3. Takeichi M. Morphogenetic roles of the classical cadherins. Curr Opin Cell Biol 1995;7:619-27.
4. Suzuki ST. Structural and functional diversity of cadherin superfamily involved in signal transduction pathway? J Cell Biochem 1996;61:531-42.
5. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993;9:317-21.
6. Butz S, Kemler R. Distinct cadherin-catenin complexes in Ca2+-dependent cell-cell adhesion. FEBS Lett 1994;355:195-200.
7. Nathke SI, Hinck L, Swedlow JR, Papkoff J, Nelson WJ. Defining interactions and distributions of cadherin and catenin complexes in polarized cells. J Cell Biol 1994;125:1341-52.
8. Huber O, Bierkamp C, Kemler R. Cadherins and catenins in development. Curr Opin Cell Biol 1996;8:685-91.
9. Nagafuchi A, Takeichi M, Tsukia S. The 102 kD cadherin-associated protein: similarity to vinculin and post-transcriptional regulation of expression. Cell 1991;65:849-57.
10. Knudsen KA, Soler AP, Johnson KR, Wheelock MJ. Interaction of α-actinin with the cadherin-catenin cell-cell adhesion via α-catenin. J Cell Biol 1995;130:67-77.
11. Birchmeier W, Behrens J, Weidner KM, Frixen UH, Schipper J. Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol 1991;3:832-40.
12. Okegawa T, Li Y, Pong RC, Hsieh JT. Cell adhesion proteins as tumor suppressors. J Urol 2002;167:1836-43.
13. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer J Clin Invest 2002;109:987-91.
14. Hajara KM, Fearon ER. Cadherin and catenin alterations in human cancer. Gene Chromosome Cancer 2002;34:255-68.
15. Cavallaro U, Schaffhauser B, Christofori G. Cadherins and tumor progression: is it all in a switch? Cancer Lett 2002;176:123-8.
16. Bussemakers MJ, Van Bokhoven A, Tomita K, Jansen CF, Schalken JA. Complex cadherin expression in human prostate cancer cells. Int J Cancer 2000;85:446-50.
17. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-4.
18. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996;135:1643-54.
19. Sunfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brannstrom M, Janson PO, Enerback S, Hedin L. E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int J Cancer 1997;74:275-80.
20. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC. The biology of ovarian cancer. Semin Oncol 1998;25:281-304.
21. Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Trope CG, Kristensen GB, Bryne M, Ann Florenes V. E-cadherin and alpha-, beta, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol 2000;192:460-69.
22. Attanoos RL, Webb R, Dojcinov SD, Gibbs AR. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathol 2002;40:237-40.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
24. Suzuki S, Sano K, Tanihara H. Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell Regul 1990;2:261-70.
25. MacCalman CD, Bardeesy N, Holland PC, Blaschuk OW. Non coordinate developmental regulation of N-cadherin, N-CAM, integrin, and fibronectin mRNA levels during myoblast terminal differentiation. Dev Dyn 1992;2:127-32.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
27. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci USA 1979;76:4350-5.
28. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999;59:947-52.
29. Radice GL, Ferreira-Cornwell MC, Robinson SD, Rayburn H, Chodosh LA, Takeichi M, Hynes RO. Precocious mammary gland development in P-cad-deficient mice. J Cell Biol 1997;139:1025-32.
30. Hines MD, Jin HC, Wheelock MJ, Jensen PJ. Inhibition of cadherin function differentially affects markers of terminal differentiation in cultured human keratinocytes. J Cell Sci 199;112:4569-79.
31. Hirai Y, Nose A, Kobayashi S, Takeichi, M. Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. 1 Skin morphogenesis. Development 1989;105:271-77.
32. Auersperg N, Wong AST, Choi KC, Hang KS, Leung PCKL. Ovarian surface epithelium: biology, endocrinology and pathology. Endocrine Rev 2001;22:255-88.
33. Simonneau L, Kitagawa M, Suzuki S, Thiery JP. Cadherin-11 expression marks the mesenchymal phenotype: towards new functions for cadherins? Cell Adhes Commun 1995;3:115-30.
34. Peralta Soler A, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H. Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinos from serous and endometrioid tumors. Hum Pathol 1997;28:734-39.
35. Sellar GC, Li L, Watt KP, Nelkin BD, Rabiasz GJ, Stronach EA, Miller EP, Porteous DJ, Smyth JF, Gabra H. BARX2 induces cadherin-6 expression and is a functional suppressor of ovarian cancer progression. Cancer Res 2001;61:6977-81.
36. Stewart DB, Barth AI, Nelson WJ. Differential regulation of endogenous cadherin expression in Madine Darby canine kidney cells by cell-cell adhesion and activation of β-catenin signaling. J Biol Chem 2000;275:20707-16.
37. Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA. Complex cadherin expression in renal cell carcinoma. Cancer Res 1996;56:3234-37.
38. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J. Altered cadherin and catenin complexes in the Barret's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. Am J Pathol 1998;152:135-44.
39. Boer de CJ, van Dorst E, van Krieken H, Jansen-van Rhijn CM, Warnaar SO, Fleuren GJ, Litvinov SV. Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. Am J Pathol 1999;155:505-15.
40. Peralta Soler A, Knudsen KA, Salazar H, Han AC, Keshgegian AA. P-cadherin expression in breast carcinoma indicates poor survival. Cancer 1999;86:1263-72.
41. Haq A, Jankowski I, Levine T, Winslet M, Morton D, Ogunbiyi O. Abnormal P-cadherin and altered expression of β-catenin in ulcerative colitis associated dysplasia and colorectal cancer. Dis Colon Rectum 2001;44:A2-4.
42. Gamallo C, Palacois J, Moreno G, Calvo de Mora J, Suarez A, Armas A. B-catenin expression pattern in Stage I and Stage II ovarian carcinomas. Am J Pathol 1999;155:527-36.
43. Fujioka T, Takebayashi Y, Kihana T, Kusanagi Y, Hamada K, Ochi H, Uchida T, Fukumoto M, Ito M. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma. Oncol Rep 2001;8:249-55.
44. Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M, Drabbin HA. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 2001;85:64-8.
45. Hecht A, Kemler R. Curbing the nuclear activities of β-catenin. Control over Wnt target gene expression. EMBO Rep 2000;1:24-8.